Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease breast cancer
Symptom C0279130|cns metastases
Sentences 13
PubMedID- 20200040 Contrary to trastuzumab, lapatinib has activity against cns metastases in patients with her-2+ breast cancer .
PubMedID- 20542996 More recently, lapatinib plus capecitabine was evaluated in a lapatinib expanded access program (leap) and a french authorisation temporaire d'utilisation (atu) program for erbb2+ breast cancer patients with cns metastases (58).
PubMedID- 20345334 Nevertheless, new treatment choices have emerged considering cytotoxic and biological agents for the treatment of cns metastases in patients with breast cancer.
PubMedID- 23740934 cns metastases among women with breast cancer tend to occur among those who are younger, have larger tumors, and have a more aggressive histological subtype such as the triple negative and her2-positive subtypes.
PubMedID- 21253507 Historically, the incidence of clinically appearing cns metastases in patients with breast cancer is 10–20%.
PubMedID- 23718256 These median survival times were much longer than that predicted by the rtog rpa and suggest that patients with cns metastases due to breast cancer survive longer than patients with cns metastases as a whole.
PubMedID- 24191208 Based on our single case observation, capacitabine and lapatinib combination therapy seems as the best choice for breast cancer patients with only cns metastases.
PubMedID- 25433950 cns metastases in breast cancer patients: prognostic implications of tumor subtype.
PubMedID- 21871802 Herein, we retrospectively analyzed clinicopathologic data of 259 breast cancer patients with cns metastases to evaluate the association between breast cancer subtypes and cns metastasis.
PubMedID- 24298071 cns metastases in breast cancer: old challenge, new frontiers.
PubMedID- 26277099 Methods: information on 992 breast cancer patients with cns metastases (whose primary tumour was diagnosed between 2004 and 2010) was retrieved from the netherlands cancer registry (ncr).
PubMedID- 21987585 This report describes this detection method and demonstrates the feasibility and significance of ctc detection in a pilot study of metastatic breast cancer patients with cns metastases.
PubMedID- 23115660 Kim et al.17) reported that in 400 patients with cns metastases of breast cancer, 318 patients (79.5%) had pbm only, 52 patients (13%) had both pbm and lmc, and 30 patients (7.5%) had lmc only.

Page: 1